The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
HOP-STEPsIRB
The HOP-STEP (Healthy Outcomes in Pregnancy With SLE Through Education of Providers) Intervention: Improving Maternal Health in Women With Lupus Through Improved Pregnancy Prevention and Planning sIRB
2 other identifiers
interventional
14
1 country
1
Brief Summary
While the HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) program has been demonstrated to be effective in improving provider confidence, increasing contraception documentation, and facilitating equitable pregnancy planning care in a single sub-specialty clinic here at Duke, the delivery of HOP-STEP may need to be changed to increase its fit with the local context at the University of Chicago Medical Center (UCMC) and subsequent locations. Thus, the investigators will now fit the intervention into a high-minority, high-poverty academic rheumatology center, and later pilot it through a randomized trial to identify and overcome existing barriers to equitable pregnancy prevention and planning at another institution (The University of Chicago Medical Center). The objective of this study is to prepare for a multi-center trial of the HOP-STEP intervention by fitting and then piloting its implementation and measuring its potential impact on maternal outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2023
CompletedFirst Posted
Study publicly available on registry
April 18, 2023
CompletedStudy Start
First participant enrolled
October 7, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedMay 6, 2026
May 1, 2026
1.3 years
April 5, 2023
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Contraception Documentation
Yes/No: Documentation of contraception use during patient visit; includes if the provider documents that the patient does not use any contraception. This is extracted from the patient's medical record and is part of the HOP-STEP intervention. This will also be analyzed by patient-level characteristics: race, age, teratogen use. Denominator: all eligible patients.
Intervention Period, up to 12 months
Secondary Outcomes (12)
Reach: Pregnancy intention documentation
Intervention Period, up to 12 months
Reach: Contraceptive Counseling
Intervention Period, up to 12 months
Reach: Pregnancy planning
Intervention Period, up to 12 months
Effectiveness: ACR-aligned contraception
Intervention Period, up to 12 months
Effectiveness: Effective and/or highly effective contraception
Intervention Period, up to 12 months
- +7 more secondary outcomes
Study Arms (2)
Routine Care Providers
EXPERIMENTALCare Providers in this arm will continue seeing patients as normal in clinic.
HOP-STEP (Healthy Outcomes in Pregnancy with SLE Through Education of Providers) Providers
EXPERIMENTALHOP-STEP providers will inquire and document their patients about contraceptive usage and pregnancy interest, then provide personalized guidance on family planning.
Interventions
Providers will continue to provide reproductive healthcare in their current manner.
The HOP-STEP Intervention is simple with 3-steps: (1) ascertain and document current pregnancy intention and contraceptive use, (2) patient and provider collaboratively arrive at her optimal contraceptive and/or pregnancy plan using a Decision Guide directed conversation, and (3) create a warm handoff with a patient-specific SLE risk assessment and guideline-aligned recommendations.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- National Institutes of Health (NIH)collaborator
- University of Chicagocollaborator
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)collaborator
Study Sites (1)
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Megan E Clowse, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2023
First Posted
April 18, 2023
Study Start
October 7, 2024
Primary Completion
January 31, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share